rs386833915
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_004646.4(NPHS1):c.2491C>T(p.Arg831Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.2491C>T | p.Arg831Cys | missense_variant | Exon 18 of 29 | 1 | NM_004646.4 | ENSP00000368190.4 | ||
NPHS1 | ENST00000353632.6 | c.2491C>T | p.Arg831Cys | missense_variant | Exon 18 of 28 | 5 | ENSP00000343634.5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251168Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135774
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461744Hom.: 0 Cov.: 33 AF XY: 0.0000275 AC XY: 20AN XY: 727180
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74344
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Pathogenic:4
- -
- -
- -
- -
NPHS1-related disorder Pathogenic:1
The NPHS1 c.2491C>T variant is predicted to result in the amino acid substitution p.Arg831Cys. This variant has been reported in the heterozygous state (Lenkkeri et al. 1999. PubMed ID: 9915943; Liu et al. 2001. PubMed ID: 11726550) and in the homozygous and compound heterozygous state (Caridi et al. 2009. PubMed ID: 19406966; Ovunc et al. 2012. PubMed ID: 22584503) in individuals with congenital nephrotic syndrome. Functional studies found this variant causes defective protein trafficking resulting in a lack of trafficking to the plasma membrane; additionally, sodium 4-phenylbutyrate (4-PBA) was able to rescue the trafficking defect and is able to function indistinguishably from wild-type nephrin (Liu et al. 2004. PubMed ID: 15213260). This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-36333296-G-A). This variant is interpreted as pathogenic. -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 831 of the NPHS1 protein (p.Arg831Cys). This variant is present in population databases (rs386833915, gnomAD 0.004%). This missense change has been observed in individual(s) with nephrotic syndrome (PMID: 19406966, 22584503, 25533962). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 56476). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPHS1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects NPHS1 function (PMID: 15213260). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at